Company

PathAI

vendor2 tracked tools

imaging_diagnostics category intelligence

Tracked Tools by PathAI

PathAI is a leading AI-powered pathology platform that applies machine learning to whole-slide pathology images for cancer diagnosis, biomarker quantification, and drug development support. The platform serves both clinical diagnostics (helping pathologists with more accurate and consistent diagnoses) and biopharma research (enabling quantitative tissue analysis for clinical trials and companion diagnostic development). PathAI has partnerships with major pharmaceutical companies and diagnostic laboratories.

Not in Active Coverage

Pathos AI

Company Intelligence

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications

3 days agodeployment

PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform

3 days agoevidence

PathAI Receives FDA Clearance for AISight Dx Platform for Primary Diagnosis

4 days agofda

PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions

4 days agodeployment

Liver Explore predictions were consistent with manual pathologist annotations

7 days agoevidence

PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm

8 days agofda

PathAI and A.C.Camargo Cancer Center announce cooperation to expand digital pathology with AI in Brazil via SUS

12 days agodeployment

PathAI and Moffitt Cancer Center announce strategic collaboration to deploy the AISight Dx digital pathology platform

14 days agodeployment

FDA 510(k) Clearance Summary for AISight Dx

15 days agofda

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

17 days agofda

PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExplore™ for Standardized Histopathology Endpoints

21 days agoevidence

PathAI and A.C.Camargo Cancer Center Announce Cooperation to Expand Digital Pathology with AI in Brazil via SUS

22 days agodeployment

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

23 days agofda

PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight® Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows

23 days agodeployment

PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm

24 days agofda